top of page
Already proven - finally approved
The AI platform for predictible orphan drugs asset generation
Our AI platform identifies, validates and accelerates regulatory pathways for rare disease treatments.
73%
Workflow automation with AI
11
Orphan Drug Designations granted
16
FDA Orphan Drug Designation submissions
bottom of page